Bloom's Syndrome. XII. Report from the Registry for 1987

Clinical Genetics

Volumn 35, Issue 1, 1989, Pages 57-69

  German, James ^a   Passarge, Eberhard ^b  

^a NEW YORK BLOOD CENTER   (United States)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Bloom's syndrome; cancer; cancer epidemiology; cancer genetics; diabetes mellitus; immunodeficiency; registry

Indexed keywords

BLOOM SYNDROME; CANCER; GENETIC REGISTRY; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYNDROME DELINEATION;

ADOLESCENT; ADULT; BLOOM SYNDROME; CHILD; CHILD, PRESCHOOL; GENETIC MARKERS; HUMAN; INFANT; MIDDLE AGE; MUTATION; NEOPLASMS; REGISTRIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024591985     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1989.tb02905.x     Document Type: Article

References (65)

1. Bloom's syndrome in a Japanese boy with lymphoma
2. The syndrome of congenital telangiectatic erythema and stunted growth
3. Effects of Bloom's syndrome fibroblasts on genetic recombination and mutagenesis of herpes simplex virus type I
4. The origin of human cancers
5. Altered DNA ligase activities in Bloom's syndrome
6. Regulation of hypoxantine DNA glycosylase in normal human and Bloom's syndrome fibroblasts
7. An amino‐acid substitution involved in phenylketonuria is in linkage disequi‐ librium with DNA haplotype 2
8. Organ site specificity for cancer in chromosomal instability disorders
9. Leukemia in a black child with Bloom's syndrome
10. Bloom's syndrome. I. Genetical and clinical observations in the first twenty‐seven patients
11. Genetic disorders associated with chromosomal instability and cancer
12. Bloom's syndrome. II. The prototype of human genetic disorders predisposing to chromosome instability and cancer
13. Bloom's syndrome. VIII. Review of clinical and genetic aspects
14. Patterns of neoplasia associated with the chromosome‐breakage syndromes
15. The significance of identifying a cancer‐predisposed person ‐ lessons From the chromosome‐breakage syndromes
16. Bloom's syndrome. V. Surveillance for cancer in affected families
17. Bloom's syndrome. VI. The disorder in Israel, and an estimation of the gene frequency in the Ashkenazim
18. Bloom's syndrome. VII. Progress report for
19. Bloom's syndrome. XI. Progress report for 1983
20. Bloom's syndrome. IX. Review of cytological and biochemical aspects
21. Bloom's syndrome. XIV. The disorder in Japan
22. Molecular evidence for unequal sister‐chromatic exchange in Bloom's syndrome
23. Molecular evidence for somatic recombination in vitro in Bloom's syndrome cells
24. Diphtheria toxin resistance in human fibroblast cell strains from normal and cancer‐prone individuals
25. Altered temporal expression of DNA repair in hypermutable Bloom's syndrome cells
26. 5‐bromodeoxyuridine‐dependent increase in sister chromatid exchange formation in Bloom's syndrome is associated with a reduction in topoisomerase 11 activity
27. A DNA‐re‐combinogenic activity in human cells
28. Protease inhibitors reduce the frequency of spontaneous chromosome abnormalities in cells from patients with Bloom syndrome
29. 6‐methylguanine methyl‐transferase increases before S phase in normal human cells but does not increase in hypermu‐table Bloom's syndrome cells
30. Cytogenetics of Bloom's syndrome
31. Sister‐chromatid exchanges induced by ultraviolet light in Bloom's syndrome fibroblasts
32. Hypersensitivity of Bloom's syndrome fibroblasts to N‐ethyl‐N‐nitrosourea
33. Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children
34. Evidence for increased somatic cell mutations at the glycophorin A locus in atomic bomb survivors
35. Bloom's syndrome: use of the glycophorin A (GPA) assay to demonstrate an excessive accumulation of mutations in vivo
36. Evidence for elevated in vivo mutation and somatic recombination in Bloom's syndrome
37. Sister chromatid exchange formation
38. 12‐O‐tetradecanoylphorbol 13‐acetate‐inducible proteins are synthesized at an increased rate in Bloom syndrome fibroblasts
39. Pregnancy in Bloom's syndrome
40. Bloom's syndrome
41. Relation of topoisomerase II activity to DNA single‐strand breaks induced by 5‐bromodeoxyuridine, topoisomerase II inhibitors, or 313 nm ultraviolet light in Bloom syndrome fibroblasts
42. The chromosome changes in Bloom's syndrome, ataxia‐telangiectasia, and Fanconi's anemia. In Genes
43. Sister‐chromatid exchange in the chromosome breakage syndromes
44. The cytogenetics of the “chromosome‐breakage syndromes.”
45. Bloom's syndrome and EM9 cells in BrdU‐containing medium exhibit similarly elevated frequencies of sister‐chromatid exchange but dissimilar amounts of cellular proliferation and chromosome disruption
46. Bloom syndrome in a Mexican mestizo girl
47. Evidence for chromosome instability in vivo in Bloom syndrome: increased numbers of micronuclei in exfoliated cells
48. Effect of deoxynucleosides on the frequency of sister chromatid exchanges in Bloom syndrome cells
49. Analyses of bromodeoxyuridine‐associated sister chromatid exchanges (SCEs) in Bloom syndrome based on cell fusion: single and twin SCEs in endoreduplication
50. Malignant transformation of Bloom syndrome B‐lymphoblastoid cell lines by carcinogens
51. Hypersensitive character of Bloom syndrome B‐lymphoblastoid cell lines usable for sensitive carcinogen detection
52. SCE levels in Bloom‐syndrome cells at very low bromodeox‐yuridine (BrdU) concentrations: Monoclonal anti‐BrdU antibody
53. Bloom's syndrome. XIII. DNA‐polymerase activity of cultured lymphoblastoid cells
54. Bloom's syndrome with porokeratosis of Mibelli and multiple cancers of the skin, Jung and colon
55. Presence of abnormally high incidences of sister chromatid exchanges in three successive cell cycles in Bloom's syndrome lymphocytes
56. Bloom's syndrome: Evidence for an increased mutation frequency in vivo
57. Monoclonal antibodies detect conformational abnormality of uracil DNA glycosylase in Bloom's syndrome cells
58. Elevated spontaneous mutation rate in Bloom syndrome ffi‐broblasts
59. Bloom syndrome: A single complementation group defines patients of diverse ethnic origin
60. DNA ligase I deficiency in Bloom's syndrome
61. Structural alterations of DNA ligase I in Bloom syndrome
62. Abnormal regulation of uracil‐DNA glycosylase induction during cell cycle and cell passage in Bloom's syndrome fibroblasts
63. Adenovirus recombination in normal and repair‐deficient human fibroblasts